4//SEC Filing
Rickard Jason 4
Accession 0001209191-22-014650
CIK 0001446847other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:00 PM ET
Size
12.5 KB
Accession
0001209191-22-014650
Insider Transaction Report
Form 4
Rickard Jason
SVP, Chief Operating Officer
Transactions
- Sale
Class A Common Stock
2022-02-28$10.77/sh−1,913$20,603→ 354,162 total - Sale
Class A Common Stock
2022-02-28$10.77/sh−3,150$33,926→ 351,012 total - Sale
Class A Common Stock
2022-02-28$10.77/sh−6,022$64,857→ 344,990 total - Sale
Class A Common Stock
2022-02-28$10.77/sh−11,057$119,084→ 333,933 total - Sale
Class A Common Stock
2022-02-28$10.77/sh−6,820$73,451→ 327,113 total
Footnotes (5)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 29, 2019.
- [F3]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.
- [F4]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting of the reporting person's performance-based restricted stock units granted on February 27, 2020.
- [F5]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 22, 2021.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001808505
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:00 PM ET
- Size
- 12.5 KB